Cite

HARVARD Citation

    Storti, P. et al. (2020). CD14+CD16+ monocytes are involved in daratumumab‐mediated myeloma cells killing and in anti‐CD47 therapeutic strategy. British journal of haematology. pp. 430-436. [Online]. 
  
Back to record